Mider: Medtronic plans to pick up a $25 million tax bill for Chief Executive Officer Omar Ishrak, the cost of a special penalty imposed by Congress on executives who shift their company’s... [read post]

We start with the June 21, 2011 document request letter sent by Grassley and Baucus to Omar Ishrak, the Chairman and CEO of Medtronic, Inc., which sets forth the reasons for this Senate investigation: We are extremely troubled by press reports suggesting that doctors conducting clinical trials examining the safety and effectiveness of Infuse on behalf of Medtronic were aware that Infuse, a treatment commonly used in spinal surgery, may cause medical complications, but failed to… [read post]